Next Generation Diagnostics Summit
20 August, 2013 - 22 August, 2013 Hyatt Regency Washington on Capitol Hill, Washington, DC, USA
About the Summit
Technological advances in next generation diagnostics are driving growth and innovation in healthcare. Rapid and precise diagnosis is essential for personalized medicine and will change the way value is assessed and compensated in the healthcare system. This meeting offers a comprehensive view of the changing landscape of diagnostics and brings together the key players in the field.
The Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Cancer Molecular Markers to Guide Therapy, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Molecular Profiling of Circulating Tumor Cells) is designed to bring together all of the major players in the evolving areas of diagnostics. This year, we have assembled an impressive faculty of speakers from industry, government, and leading academic institutions. This meeting will showcase improvements in technology research and development with an emphasis on applications in the clinic and commercialization. Plan to hear what the industry leaders are saying about future market opportunities and network with your peers this August 20-22 in Washington, DC.
PLENARY KEYNOTE DISCUSSION
Perspectives on Evaluating Novel Diagnostics for Reimbursement
Andrew C. Fish,
Executive Director, AdvaMedDx
Elaine K. Jeter, M.D.,
J1 MolDx Medical Director, Palmetto GBA
Lee H. Newcomer, M.D.,
Senior Vice President, Oncology, United Healthcare
Dwight Denham, MBA,
Director, Clinical Research, Beckman Coulter, Inc.
Aaron D. Bossler, M.D., Ph.D.,
Clinical Assoc. Prof., Dir., Mol. Pathology Lab and Mol. Genetic Pathology Fellowship Program, Univ. of Iowa Hospitals and Clinics and Co-Chair, AMP Economic Affairs Committee